- P. K. Singh
- K. K. Singh
- L. S. Rathore
- A. K. Baxla
- S. C. Bhan
- G. B. Gohain
- R. Balasubramanian
- R. S. Singh
- R. K. Mall
- Ashutosh Sharma
- Rajiv K. Tayal
- Neelima Alam
- G. V. Raghunath Reddy
- Vineet Saini
- J. B. V. Reddy
- Ranjith Krishna Pai
- Ligy Philip
- Prasada Raju
- T. Pradeep
- Sompal Singh
- Vimal Yadav
- Jaydeep S. Yadav
- Swati Rawat
- S. Rawat
- Arun Pandey
- Mayuri Gandhi
- Jaydeep Singh Yadav
- Vikas Chaurasia
- Saurabh Pal
- G. Bala
- Anil V. Kulkarni
- S. Pratibha
- Nisha Mendiratta
- H. K. Mittal
- A. Mukhopadhyay
- Neeraj Sharma
- Rajiv Tayal
- Prabhanshu Gupta
- Shradha Sangali
- Perminder Jit Kaur
- Monika Agarwal
- Current Science
- Asian Journal of Pharmaceutical Analysis
- Asian Journal of Pharmacy and Technology
- Asian Journal of Research in Pharmaceutical Sciences
- Asian Journal of Pharmaceutical Research
- Research Journal of Topical and Cosmetic Sciences
- Research Journal of Pharmaceutical Dosage Form and Technology
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Gupta, Akhilesh
- Rice (Oryza sativa L.) Yield Gap Using the CERSE-Rice Model of Climate Variability for Different Agroclimatic Zones of India
Authors
1 Agromet Service Cell, India Meteorological Department, Lodhi Road, New Delhi 110 003, IN
2 Deparment of Science and Technology, New Delhi 110 016, IN
3 Agrimet Pune, New Delhi 411 005, IN
4 Banaras Hindu University, Varanasi 221 005, IN
Source
Current Science, Vol 110, No 3 (2016), Pagination: 405-413Abstract
The CERES (crop estimation through resource and Environment Synthesis)-rice model incorporated in DSSAT version 4.5 was calibrated for genetic coefficients of rice cultivars by conducting field experiments during the kharif season at Jorhat, Kalyani, Ranchi and Bhagalpur, the results of which were used to estimate the gap in rice yield. The trend of potential yield was found to be positive and with a rate of change of 26, 36.9, 57.6 and 3.7 kg ha-1 year-1 at Jorhat, Kalyani, Ranchi and Bhagalpur districts respectively. Delayed sowing in these districts resulted in a decrease in rice yield to the tune of 35.3, 1.9, 48.6 and 17.1 kg ha-1 day-1 respectively. Finding reveals that DSSAT crop simulation model is an effective tool for decision support system. Estimation of yield gap based on the past crop data and subsequent adjustment of appropriate sowing window may help to obtain the potential yields.Keywords
Agroclimatic Zones, Genetic Coefficients, Rice Model, Yield Gap.References
- Patel, H. R. and Shekh, A. M., Yield gap and trend analysis of wheat using CERES-wheat model in three districts of Gujarat state. J. Agrometeorol., 2006, 8(1), 28–39.
- Patel, V. J., Patel, H. R. and Pandey, V., Estimation of wheat yield gap in Anand and Panchmahal districts using CERES-wheat model. J. Agrometeorology. (Spec. Issue-part-2), 2008, 393–397.
- Bell, M. A. and Fischer, R. A., Using yield predication to assess yield grains: a case study for wheat. Field Crops Res., 1994, 36, 161–166.
- Aggarwal, P. K. and Kalra, N., Analysing the limitation set by climatic factors, genotype and water and nitrogen availability on productivity of wheat II. Climatic potential yield and management strategies. Field Crops Res., 1994, 38, 93–103.
- Aggarwal, P. K., Hebbar, K. B., Venugopalan, M. V., Rani, S., Bala, A., Biswal, A. and Wani, S. P., Quantification of yield gaps in rain-fed rice, wheat, cotton and mustard in India. Global theme on agro ecosystems, report no. 43 and page 36, ICRISAT, Hyderabad, 2008.
- Pathak, H. et al., Trend of climatic potential and on-farm yield of rice and wheat in the Indo-Gangetic Plains. Field Crops Res., 2003, 80, 223–234.
- Wickham, T. H., Predicting yield in lowland rice through a water balance model in Philippine irrigation systems: research and operations. International Rice Research Institute (IRRI), Los Banos, Philippines, 1973, pp. 155–181.
- Ahuja, S. P., Computer simulation of primary production of semiaquatic system using rice (Oryza sativa). Analysis and modeling of the physics of biological–climatological coupling. Ph D thesis, University of California, Devis, 1974.
- Angus, J. F. and Zandstra, H. G., Climatic factors and the modeling of rice growth and yield. In Agrometeorology of the Rice Crop, IRRI, Los Banos, Philippines, 1979, pp. 189–199.
- Kropff, M. J., Van Laar, H. H. and Mathews, R. B. (eds), ORYZA1, an ecophysiological model for irrigated rice production. In SARP Research Proceedings, AB-DLO and TPE-WAU, Wageningen and IRRI, Los Banos, 1994, p. 110.
- Penning de Vries, F. W. T., Jnasen, D. M., Ten Berge, H. F. M. and Bakema, A. H., Simulation of Ecophysiological Processes of Growth of Several Annual Crops, PUDOC, Wageningen, 1989, p. 271.
- Whisler, F. D., Sensitivity test of the crop variables in RICEMOD, IRRI, Res., Pap. Ser., 1983, pp. 89–103.
- Attachai, J., A decision support system for rapid assessment of low land rice-based alternative in Thailand. Agric. Syst., 1995, 47, 245–258.
- Diwakar, M. C. (ed.), Rice in India during 10th Plan, Directorate of Rice Development, Patna, 2009.
- Ritchie, J. T., Wheat phasic development, In Modelling Plant and Soil System (eds Hanks, J. and Ritchie, J. T.), Agron. Mongr., ASA, CSSA, Madison, WI, USA, 1991, p. 31.
- Singh, K. K., Baxla, A. K., Singh, P. K. and Balasubramanian, R., A report on database for rice cultivars used in CERES-rice crop simulation model in different agroclimatic zones of India, Agromet Service Cell, New Delhi, 2010.
- Singh, P. K., Singh, K. K., Baxla, A. K., Rathore, L. S., Kumar, B., Balasubramanian, R. and Tyagi, B. S., Crop yield prediction using CERES-rice model for the climate variability of South Bihar alluvial zone of Bihar (India). AP Chapter of Association of Agrometeorologists National Symposium on Agro Meteorology, at Central Research Institute for Dry land Agriculture (CRIDA), Hyderabad, 2013, pp. 22–23.
- Singh, P. K., Singh, K. K., Baxla, A. K. and Rathore, L. S., Impact of climatic variability on Rice productivity using CERES-rice models Eastern plain zone of Uttar Pradesh. In Third International Agronomy Congress on ‘Agriculture Diversification, Climate Change Management and Livelihoods’, IARI, New Delhi, 26–30 November 2012 and extended summaries vol. (2), 2012, pp. 236– 237.
- Sinha, S. K., Singh, G. B. and Rai, M., Decline in Crop Productivity in Harayana and Punjab: Myth or Reality? Indian Council of Agricultural Research, New Delhi, 1998, p. 89.
- Bhandari, A. L., Ladha, J. K., Pathak, H., Padre, A. T., Dawe, D. and Gupta, R. K., Trend of yield and soil nutrient status in longterm rice–wheat experiment in the Indo-Gangetic Plains of India. Soil Sci. Soc. Am. J., 2002, 66, 162–170.
- Yadav, R. L., Diwivedi, B. S., Orsad, K., Tomar, O. K., Shurapali, N. J. and Pandey, P. S., Yield trends and changes in soil organic-C and available NPK in a long-term rice–wheat system under integrated use of manures and fertilizers. Field Crops Res., 2000, 68, 219–246.
- Akula, B., Estimating wheat yields in Gujarat using WTGROWS and INFOCROP models. Ph D thesis, Anand Agriculture University, Sardar Krishinagar, Anand, Gujarat, India, 2003.
- Mall, R. K. and Srivastava, M. K., Prediction of potential and attainable yield of wheat: a case study on yield gap. Mausam, 2002, 53, 45–52.
- Sanjay Bajpai (1965–2021)
Authors
1 Department of Science and Technology, New Delhi 110 016, IN
2 Department of Civil Engineering, Indian Institute of Technology Madras, Chennai 600 036, IN
3 Industrial Consultancy and Sponsored Research, Indian Institute of Technology Madras, Chennai 600 036, India (former Scientist, DST), IN
4 Department of Chemistry, Indian Institute of Technology Madras, Chennai 600 036, IN
Source
Current Science, Vol 120, No 11 (2021), Pagination: 1790-1791Abstract
No Abstract.Keywords
No Keywords.- Impact of Projected Climate Change on Rice (Oryza sativa L.) Yield Using CERES-Rice Model in Different Agroclimatic Zones of India
Authors
1 Agromet Service Cell, India Meteorological Department, Lodhi Road, New Delhi 110 003, IN
2 Department of Agriculture Meteorology, Punjab Agriculture University, Ludhiana 141 004, IN
3 Department of Science and Technology, New Delhi 110 016, IN
Source
Current Science, Vol 112, No 01 (2017), Pagination: 108-115Abstract
Climate change is projected to alter the growing conditions of rice crop in different regions of India. Crop growth simulation model (DSSATv4.6) was calibrated and evaluated with four rice cultivars: PR 118 in Amritsar, Ludhiana; HKR 126 in Hisar and Ambala; Pant 4 in Kanpur and Sugandha-1126 in Modipuram on different sowing dates. The average yield of the selected optimum dates was 6391, 6531, 7751, 7561, 4347 and 4131 kg/ha for Amritsar, Ludhiana, Hisar, Ambala, Modipuram and Kanpur respectively. Both temperature and CO2 have increased. The combined effect of temperature and CO2 indicates decreased yield rate in the future decades. The present study shows that rice yield will decrease in the future and this may be due to increase in temperature. According to projection results, for all the locations average yield is higher in the decade 2010, except Amritsar in the decade 2030 and Ludhiana in the decade 2050. The average yield at Hisar, Ambala, Modipuram and Kanpur in 2010 was 7744, 7654, 4347 and 4021 kg/ha respectively. Amritsar and Ludhiana showed maximum average yield of 6880 and 6877 kg/ha respectively, in the decade 2030. Such yield reductions in rice crops due to climate change are mediated through reduction in crop duration, grain number and grain filling duration. These projections nevertheless provide a direction of likely change in crop productivity in future climate change scenarios.Keywords
Agroclimatic Zones, Climate Change, Crop Simutation Models, Rice.- An Analytical Approach of Doxofylline:A Review
Authors
1 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
2 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 1, No 4 (2011), Pagination: 67-70Abstract
Doxofylline is chemically designated as 7-(1, 3 dioxolone-2-yl methyl) theophylline. Presence of a dioxolane group in position C-7 differentiates it from theophylline. It is a new antibronchospastic drug recently introduced in therapy with pharmacological properties like theophylline; a potent adenosine receptor antagonist. doxofylline do not affect gastric acid secretion; either invivo or in-vitro; unlike theophylline. The lack of side effects with doxofylline indicates that the drug can be used safely and effectively. Some analytical methods for quantitative determination of doxofylline in pharmaceutical formulations like UV-Spectrophotometry, HPLC and LC-MS are reported. The present review deals with the various analytical methods reported as well as adopted for the estimation of doxofylline.Keywords
Doxofylline, UV, HPLC, LC-MS.- Spectrophotometric Method for Simultaneous Estimation of Nimesulide and Diclofenac Sodium in Pharmaceutical Dosage Forms
Authors
1 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
2 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P), IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 1, No 4 (2011), Pagination: 85-87Abstract
A simple accurate spectrophotometric method has been developed for simultaneous estimation of nimesulide and diclofenac sodium. The method involves solving of simultaneous equation based on measurement of absorbance at two wavelengths i.e., at 276 nm and 395 nm.Keywords
Nimesulide, Diclofenac Sodium, Simultaneous Equation and UV Spectrophotometry.- Method Development and Photolytic Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS
Authors
1 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
2 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
3 Alkem Laboratories, Mumbai, IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 1, No 2 (2011), Pagination: 29-33Abstract
A simple, rapid and accurate RP-HPLC method was developed for the determination of doxofylline and photolytic degradation product. The method showed a linear response for concentrations in the range of 1-200 g/ml using acetonitrile: formic acid (90: 10); pH-3.0 as the mobile phase with detection at 274 nm and a flow rate of 1 ml/min and retention time 2.9 min. The method was statistically validated for accuracy, precision, linearity, ruggedness, robustness, forced degradation, solution stability and selectivity. Quantitative and recovery studies of the dosage form were also carried out and analyzed; the % RSD from recovery studies was found to be less than 1. Due to simplicity, rapidity and accuracy of the method, we believe that the method will be useful for routine quality control analysis. The acid degradation product as well as pathway was characterized by LC-MS/MS.Keywords
Doxofylline, RP-HPLC, LC-MS/MS, Degradation Studies.- Method Development and Acid Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS
Authors
1 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
2 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
3 IIT, Mumbai (M.S.), IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 1, No 1 (2011), Pagination: 10-13Abstract
A simple, rapid and accurate RP-HPLC method was developed for the determination of doxofylline and acid degradation product. The method showed a linear response for concentrations in the range of 1-200 μg/ml using acetonitrile: formic Acid (90: 10); pH-3.0 as the mobile phase with detection at 274 nm and a flow rate of 1 ml/min and retention time 2.9 min. The method was statistically validated for accuracy, precision, linearity, ruggedness, robustness, forced degradation, solution stability and selectivity. Quantitative and recovery studies of the dosage form were also carried out and analyzed; the % RSD from recovery studies was found to be less than 1. Due to simplicity, rapidity and accuracy of the method, we believe that the method will be useful for routine quality control analysis. The acid degradation product as well as pathway was characterized by LC-MS/MS.Keywords
Doxofylline, RP-HPLC, LC-MS/MS, Degradation Studies.- Method Development and Hydrolytic Degradation Study of Doxofylline by RP-HPLC and LC-MS/MS
Authors
1 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
2 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
3 IIT Mumbai (M.S), IN
Source
Asian Journal of Pharmaceutical Analysis, Vol 1, No 1 (2011), Pagination: 14-18Abstract
A simple, rapid and accurate RP-HPLC method was developed for the determination of doxofylline and photolytic degradation product. The method showed a linear response for concentrations in the range of 1-200 μg/ml using acetonitrile: formic acid (90:10); pH-3.0 as the mobile phase with detection at 274 nm and a flow rate of 1 ml/min and retention time 2.9 min. The method was statistically validated for accuracy, precision, linearity, ruggedness, robustness, forced degradation, solution stability and selectivity. Quantitative and recovery studies of the dosage form were also carried out and analyzed; the % RSD from recovery studies was found to be less than 1. Due to simplicity, rapidity and accuracy of the method, we believe that the method will be useful for routine quality control analysis. The hydrolytic degradation product as well as pathway was characterized by LC-MS/MS.Keywords
Doxofylline, RP-HPLC, LC-MS/MS, Degradation Studies.- Development of Novel HPTLC Method for Estimation of Qurcetine in Ocimum sanctum
Authors
1 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
Source
Asian Journal of Pharmacy and Technology, Vol 1, No 4 (2011), Pagination: 149-151Abstract
HPTLC is a modern chromatographic technique in which the principle of TLC is sophisticated and automated by which the samples are accurately and precisely estimated which can be utilized for both qualitative and quantitative purpose.
Ocimum genus contains approximately 30 species of herbs and shrubs from the tropical and subtropical region of Asia, Africa and central and South America. However, the major place of diversity appears to be in Africa. The drug has numerous pharmacological activities like hypoglycemic, immunomodulatory, antistress, analgesic, antipyretic, antiinflammatory, antiulcerogenic, radio protective and antitumor. Major constituents of Ocimum sanctum includes eugenol, qurcetine etc. which are known to possess antifungal activity against candida albicans. The aim of the present study is to develop a novel High Performance liquid chromatographic (HPTLC) method for the quantitative estimation of flavonoid Qurcetine in hydroalcoholic extract of Ocimum sanctum.
Keywords
Ocimum sanctum, Qurcetine, HPTLC.- The Modern Era: Online Pharmacy and Self Medication: Review
Authors
1 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
2 Kunwar Haribansh Singh College of Pharmacy, Jaunpur, (U.P.), IN
3 V.B.S. Purvanchal University, Jaunpur, (U.P.), IN
Source
Asian Journal of Pharmacy and Technology, Vol 1, No 1 (2011), Pagination: 4-8Abstract
Internet pharmacy is also known as online pharmacy, cyber pharmacy, e pharmacy, and virtual pharmacy/drugstores intended to help pharmacists and others to identify the legal and professional requirements. Since about the year 1999, a growing number of internet pharmacies have been established worldwide. Many of these pharmacies are similar to community pharmacies and in fact many of them are actually operated by brick and mortar community pharmacies that serve consumers online, hence, walk in their door. It was found that some customers consider this method to be more convenient and private method rather than traveling to a community drugstore. Internet pharmacies are also recommended to some patients by their physicians if they are homebound. The present review focus on the present role of online pharmacy and self medication as well as its future prospects.Keywords
Online Pharmacy, Self Medication, Cyber Pharmacy, e-Pharmacy, Virtual Pharmacy And Drugstore.- Development and Study of Wound Healing Activity of an Ayurvedic Formulation
Authors
1 Shri Bhagwan College of Pharmacy Aurangabad (M.S.), IN
2 Kunwar Haribansh Singh College of Pharmacy Jaunpur (U.P.), IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 1, No 1 (2011), Pagination: 26-28Abstract
The effect of prepared Ayurvedic formulation was evaluated on excision and incision wound models in rats. The wound-healing activity was assessed by the rate of period of epithelialization and skin-breaking strength. Histological study of the granulation tissue was carried out to know the extent of collagen formation in the wound tissue. The Ayurvedic formulation prepared was then promoted for wound-healing activity in two wound models. The treated animals showed significant reduction in the wound area up to (P<0.001) and faster rate of epithialisation (23.17±0.54). In an incision wound model, formulation treated animals demonstrated significant skin-breaking strength up to 420.33±5.92. Histological studies of the tissue obtained from the formulation treated group revealed that the activity was more significant in this group. Our present study reveals that the Ayurvedic formulation posses potent wound healing activity, which could be a good choice of remedy for wound healing but less potent than standard Nitrofurazone.Keywords
Excision Wound, Incision Wound Model, Ayurvedic Medicinal Plants.- Regulatory Requirements for Drug Development and Approval in United States:A Review
Authors
1 Shri Bhagwan College of Pharmacy, Aurangabad (M.S.), IN
2 Kunwar Haribansh Singh College of Pharmacy, Jaunpur (U.P.), IN
Source
Asian Journal of Pharmaceutical Research, Vol 1, No 1 (2011), Pagination: 1-6Abstract
In this paper a brief history and an overview of the regulatory process for drug approval in the United States through illustrations of Investigational New Drug (INDs) Applications and New Drug Applications (NDAs), abbreviated new drug applications (ANDAs) and supplemental new drug applications (SNDAs) are provided. For INDs, the regulatory requirements for a well-designed protocol, the role and responsibility of institutional review boards, and the applicability of treatment INDs are discussed. For NDAs, issues regarding the application of expanded access, the submission of abbreviated NDAs for a generic drug, the submission of supplemental NDAs for labeling changes, and the role and responsibility of advisory committees are addressed. Along with this a brief description of review steps taken by FDA is provided.Keywords
Investigational New Drug Application, New Drug Application, International Conference on Harmonization.- Geoengineering and India
Authors
1 Centre for Atmospheric and Oceanic Sciences, Indian Institute of Science, Bengaluru 560 012, IN
2 Climate Change Programme, Department of Science and Technology, New Delhi 110 016, IN
Source
Current Science, Vol 113, No 03 (2017), Pagination: 376-377Abstract
The national roundtable discussion on geoengineering was held recently in Delhi. While research on geoengineering is fairly advanced in the international arena, very little R&D efforts have been undertaken in India. Hence, the Department of Science and Technology (DST) has recently launched a Major R&D project (MRDP) at Centre for Amospheric and Oceanic Sciences (CAOS), Indian Institute of Science (IISc) to undertake climate modelling experiments in order to generate strategic knowledge on stratospheric aerosol geoengineering. The primary objective of convening the roundtable discussion on geoengineering was to seek views of the experts and policy makers on the issue of whether and how geoengineering is likely to impact India.- Clinical Importance of Aloe Vera:Review
Authors
1 Surgycare Lifescience, Sendhwa (MP), IN
2 SND College of Pharmacy, Yeola (MS), IN
Source
Research Journal of Topical and Cosmetic Sciences, Vol 8, No 1 (2017), Pagination: 30-39Abstract
John Goodyew translated first reference from term ‘Dioscorides Medical treatise De Materia Medica’ into English terminology as use of Aloe vera in A.D. 1655; moreover, in early 1800s it used as laxative whereas in the mid 1930s successful treatment was introduced for chronic and severe radiation dermatitis. Since, several cultures of the history have been showed impression of foot print for use of Aloe vera, major includes Greece, Egypt, India, Mexico, Japan and China. Egyptian queens Nefertiti and Cleopatra regularly involved it in their beauty regimes whereas Alexander the Great, and Christopher Columbus used it to treat soldiers’ wounds. Aloe vera is well known plant not only in tribal community but modern lookout also make it therapeutic important. Since it is used in Ayurvedic, Homeopathic and Allopathic medicine because various research support that it contains vitamins, minerals, enzymes, amino acids, natural sugar and other bioactive compounds. Although therapeutic use of Aloe vera covered wide range of activity major includes emollient, purgative, antimicrobial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic, its benefits so myriad and astounding that no part in human body remains uninfluenced by its healing touch; all these make it plant of wonder. The modern therapeutic approach for beauty enhancer also list Aloe vera as most favorable plant in cosmetic industries. In this review we are trying to approach and underlying every possible corner associated with medicinal use of Aloe vera.Keywords
Aloe vera, Wound Healing Agent, Antioxidant, Laxative, Anticancer, Anti Stress, Antidiabetic, Antidiabetic, Nutrient.References
- Davis, RH, Parker WL, Samson RT, and Murdoch DP. The isolation of an active inhibitory sytem from an extract of Aloe vera. J. Am Podiatr Med Assoc 81; 1991: 258-261.
- Lopez, H, Camberros LO, and Ocampo AA. Comparative evaluation of a mixture of propolis and Aloe vera with commercial wound healing products. Veterinaria 20(4); 1989:407-414.
- Tyler V. The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies, Third Edition. Pharmaceutical Products Press, Binghamton, NY. 1993.
- Grindlay D, Reynolds T. The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. J ethnopharmacology. 16(1); 1986:117–15.
- Foster S, et al. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. Haworth Herbal Press, New York. 1999.
- Davis RH. Aloe vera: A scientific approach. Vantage Press, New York. 2000.
- Brusick D, Mengs U. Assessment of the genotoxic risk from laxative senna products. Environmental and Molecular Mutagenesis 29(1); 1999:1-9.
- Okamura N, Asai M, Hine H, and Yagi A. J. Chromatography.746(1); 1996: 225-233.
- Jyotsana M, Sharma AK, Inamdar N, Harwinder Singh R and Ramnik S. Immunomodulatory properties of Aloe veragel in mice. Int J Green Pharmacy. 2(1);2008: 152-154.
- Davis RH, Leitner MG, Russo JM and Byrne ME. Wound healing. Oral and topical activity of Aloe vera. J American Paediatric Medical Association. 79(1); 1989: 559-562.
- Satish S, Raveesha KA and Janardhana GR. Antibacterial activity of plant extracts on phytopathogenic Xanthomonas campestris pathovars. Letters in Applied Microbiology 28; 1999; 145-147.
- Zhang L and Tizard IR. Activation of mouse macrophage cell line by Acemannan; the major carbohydrate fraction of Aloe vera L. Immunopharmacology 35; 1996: 119-28.
- Vogler BK and Ernst E. Aloe vera: A systematic review of its clinical effectiveness. The British journal of general practice: J Royal College of General Practitioners 49; 1999:823-828.
- King GK, Yates KM and Greenlee PG. The effect of acemannan immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J American Animal Hospital Association 31; 1995: 439 -447.
- Dagne E, Bisrat D, Viljoen A and Van Wyk BE. Chemistry of Aloe species. J Current Organic Chemistry 4; 2000: 1055-1078.,
- Ombrello T. Aloe vera . http://faculty.ucc.edu/biology - ombrello /POW /Aloe_ vera. htm 2008, Accessed 2008/06/08.
- Nassiff HA and Fajardo F, Velez F. Effect of aloe AS hiperlipidemia. Rev Cuba Med Gen Integr.9; 1993: 43-51.
- Reddy Uma CH, Reddy SK and Reddy J. Aloe vera - A wound healer. Asian Journal of Oral Health and Allied Sciences 1; 2011: 91 -92.
- Shamim S, Ahmed S, Waseemuddin and Azhar I. Anti fungal activity of Allium, Aloe, and Solanum species. Pharmaceutical Biology 42; 2004:491-498.
- Ferro VA, Bradbury F, Cameron P, Shakir E, Rahman SR and Stimson WH. In vitro susceptibilities of Shigella flexneri and Streptococcus pyogenes to inner gel of Aloe barbadensis Miller. Antimicrobial agents and chemotherapy 47; 2003: 1137-1139.
- D Jasso de Rodriguez, Hernandez Castillo D, Rodriguez Garcia R and Angulo-Sanchez J L. Antifungal activity in vitro of Aloe vera pulp and liquid fraction against plant pathogenic fungi. Industrial Crops and Products. 21; 2005: 81-87.
- Hashemi SA, Madani SA, Saied A. The Review on Properties of Aloe Vera in Healing of Cutaneous Wounds. BioMed Research International. 2015(1); 2015:1-7
- Heggie S, et al. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs. 25(6); 2002:442-51.
- Williams M, et al. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys. 36(2); 1996:345-349.
- Ganapathy N, Venkataraman SS, Daniel R. Molecular biology of wound healing. Journal of Pharmacy and Bioallied Sciences, vol. 4(6); 2012, 334-337.
- Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on collagen characteristics in healing dermal wounds in rats. Mol Cell Biochem. 181; 1998:71-76.
- Fulton JE Jr. The stimulation of postdermabrasion wound healing with stabilized aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol. 16; 1990:460-467.
- Mantle D, Gok MA, Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev. 20(2); 2001:89-103.
- Davis RH, Leitner MG, Russo JM, Byrne ME. Wound healing. Oral and topical activity of aloe vera. Journal of the American Podiatric Medical Association 79; 1989:559-562.
- Newton LE . In defence of the name Aloe vera. The cactus and succulent journal of Great Britain. 41; 1979:29-30.
- Heggers JP, Pelley RP, Robson MC. Beneficial effects of Aloe in wound healing. Phytotherapy research. 7; 1993:S48–S52.
- Shelton RM. Aloe vera, its chemical and therapeutic properties. International journal of dermatology. 30; 1991:679-683.
- Davis, RH, et al. Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. Journal of the American Podiatric Medical Association. 84(2); 1994: 77-81.
- Tizard AU et al. Effects of acemannan, a complex carbohydrate, on wound healing in young and aged rats. Wounds, a compendium of clinical research and practice 6; 1995:201-209.
- Roberts DB, Travis EL. Acemannan-containing wound dressing gels reduce radiation-induced skin reactions in C3H mice. International journal of radiation oncology, biology and physiology 15; 1995:1047-1052.
- Saroj PL, D handar DG and Singh RS. Indian Aloe. Central Institute for Arid Horticulture, Bikaner 2004: 6-10.
- Mortan JF. Folk uses and commercial exploitation of Aloe veraleaf pulp. Economic Botany15; 1961:311-319.
- Femenia A, Sanchez ES, Simal S and Rosello C. Compositional features of polysaccharides from Aloe vera (Aloe barbadensis Miller) plant tissues.arbohydr. Polym.39; 1999: 109-117.
- Sims P, Ruth M and Zimmerman ER. Effect of Aloe veraon Herpes simplex and herpes virus (strain Zoster). Aloe vera of Amer ican Archives 1;1971:239-240.
- Stone N, Meistar A. Function of ascorbic in the conversion of proline to collagen hydroxyproline. Nature 194;1965: 555-57.
- El-Shemy HA, Aboul-Soud MA, Nassr-Allah AA, Aboul-Enein KM, Kabash A and Yagi A. Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercritical carbon dioxide extraction. Current Organic Chemistry 17;2010: 129-138.
- Kirtikar KR and Basu BD. Indian Medicinal Plants. Vol. IV (IIndEd.).Pub. Lalit Mohan Basu, Allahabad, India, 1989.
- Davis HR. Aloe vera: A Scientific Approach Published by Vantage Press NewYork, SA. http://www.aloevera.co.uk/rhdavis.htm 1997, Accessed 2011/07/07.
- Barcroft SL and Alasdair NT. Aloe vera Healer, (www .JoJaffa.com), http://www.AloeVeraHealer.com, 1999, Accessed 2011/03/09.,
- Yates A. Yates Garden Guide. Harper Collins Australia 2002, pp.135-137.
- Jones K and Aloe C. The anti-diabetic activity of Aloe vera. Cosmetic Science Technology 2; 2005: 34-35
- Green P. Aloe vera extracts in equine clinical practice. Veterinary Times 26; 1996:9-12.'
- Gordon MC and David JN. Natural product drug discovery in the next millennium. Pharm. Biology39; 2001: 8-17.
- Mckeown E. Anthraquinones and anthracenic derivatives absorb UV light. Cosmetics and toiletries. 102; 1987:64-65.
- Leigh GC. Dental irrigators. Research letters Br. Dent. Journal 198; 2005: 756-763.
- Kaufman T, Kalderon N, Ullmann Y, et al. Aloe vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study.J Burn Care Rehabil. 9; 1988:156-159.
- Crowell J, Penneys N. The effects of aloe vera on cutaneous erythema and blood flow following ultraviolet B (UVB) exposure. Clin Res. 35; 1987:676A.
- Syed TA, Cheema KM, Ashfaq A, et al. Aloe vera extract 0.5% in ahydrophilic cream versus Aloe vera gel for the management of genital herpes in males. A placebo-controlled, double-blind, comparative study [letter]. J Eur Acad Dermatol Venereol. 7;1996: 294-295.
- Syed TA, Ahmad SA, Holt AH, et al. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health. 1; 1996:505-509.
- Vardy DA, Cohen AD, Tchetov T, et al. A double-blind, placebo-controlled trial of an Aloe vera (A. barbadensis) emulsion in the treatment of seborrheic dermatitis. J Dermatol Treat. 10; 1999:7-11.
- Udupa, SL, Udupa AL and Kulkarni DR. Anti-inflammatory and wound healing properties of Aloe vera. Fitoterapia. 65(2); 1994: 141-145.,
- Davis, RH et al. Aloe vera, hydrocortisone, and sterol influence on wound tensile strength and anti-inflammation. Journal of the American Podiatric Medical Association. 84(12); 1994: 614-21.
- Tucker AO, Duke JA, Foster S. Botanical nomenclature of medicinal plants. In: Cracker LE, Simon JE, eds. Herbs, spices and medicinal plants, Vol. 4. Phoenix, AR, Oryx Press, 1989:169–242.
- Robson MC, Heggers J, Hagstrom WJ. Aloe vera revisited. Journal of burn care and rehabilitation, 3; 1982:157-162.
- Udupa, SL, Udupa AL and Kulkarni DR. Anti-inflammatory and wound healing properties of Aloe vera. Fitoterapia 65(2); 1994: 141-145.
- Davis, RH, et al. Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. Journal of the American Podiatric Medical Association. 84(2); 1994: 77-81.
- Lee KH, et al. Anti-leukaemic and anti-mutagenic effects of di(2-ethylhexyl)phthalate isolated from Aloe vera Linne. J Pharm Pharmacol. 52(5); 2000:593-8.
- Pulse, T. 1988. Whole leaf Aloe vera juice used in AIDS treatment. About Aloe vera. (obtained from defunct webpage).
- Atherton Peter. Aloe vera Myth or Medicine? Positive Health Publications, www.positivehealth.com/permit/Articles/AloeVera/atherton.htm, Online, 2002, Accessed 2011/05/13.
- Rodriguez DJ, Hernandez CD, Rodríguez GR and Angulo Sanchez JL. Antifungal activity in vitro of Aloe vera pulp and liquid fraction against plant pathogenic fungi. Industrial Crops and Products 21; 2005:81-87.
- Lee JK, et al. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol. 1(7); 2001:1275-84.
- Pugh N, et al. Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity. J Agric Food Chem. 49(2); 2001:1030-4.
- Reynolds T, Aloes: The Genus Aloe, CRC press, 2004.
- Lee KH, et al. Anti-leukaemic and anti-mutagenic effects of di(2-ethylhexyl)phthalate isolated from Aloe vera Linne. J Pharm Pharmacol. 52(5); 2000:593-8.
- Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacology. 35(2); 1996:119-28.
- Furukawa F, et al. Chemopreventive effects of Aloe arborescens on N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters. Cancer Lett. 25;178(2); 2002:117-22.
- Vogler BK and Ernst E. Aloe vera: A systematic review of its clinical effectiveness. The British journal of general practice: The journal of the Royal College of General Practitioners 49;1999, 823-828.
- Yeh GY, et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 26(4); 2003: 1277-94.
- Mantle D, Gok MA, Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev. 20(2); 2001: 89-103.
- Al Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Research 18; 1991:163-168.
- Crowell J, Penneys N. The effects of aloe vera on cutaneous erythema and blood flow following ultraviolet B (UVB) exposure. Clin Res. 35; 1987:676-678.
- Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on collagen characteristics in healing dermal wounds in rats. Mol Cell Biochem. 181; 1998:71-76.
- Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 49(447); 1999:823-828.
- Ghannam N, Kingston M, Al Meshaal IA, Tariq M, Parman NS, Woodhouse N. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res. 24(4); 1986:288-94.
- Davis RH, Leitner MG, Russo JM and Byrne ME. Wound healing.Oral and topical activity of Aloe vera. Journal of the American Paediatric Medical Association 79; 1989: 559–562.
- Cheesbrough M. Medical Laboratory Manual for Tropical Countries. Vol. II, first edition. Printed and bond in Great Britain by the university Press, Cambridge 1984, pp. 372-391.
- Grindlay D and Reynadds T. The Aloe vera Phenomenon. A review of the properties and modern uses of the leaf parenchyma gel. J.Ethnopharmacol 16; 1986:117-151.
- Neall B. Aloe’s new role in functional foods. Food Review 31; 2004: 24-25.
- Anonymous. Water conservation. Chennai, India: The Hindu, India. 2008c, http://www.hindu.co/seta/2008/07/10/stories.2008071050161 800. htm . Accessed 2010/12/15.,
- Nadkerni KM. Indian Meteria Medica Vol. I (3rd ed.). Pub. Bommbay Popular Prakashan Private Limited. 1976, pp. 73-74.
- Joseph B and Justin Raj S. Pharmacognostic and phytochemical properties of Aloe vera Linn. - An overview. International Journal of Pharmaceutical Science Review and Research 2; 2010: 106-110.
- Thomson PDR. Herbal Medicines, Third Edition, NJ: Thomson PDR. 2004, Pp.16-20.
- Marshall J. Aloe vera gel: what is the evidence? Pharmaceutical Journal 244; 2000: 360-362.
- Agarry OO, Olaleye MT and Bello-Michael CO. Comparative antimicrobial activities of Aloe vera gel and leaf. African Journal of Biotechnology 4; 2005: 1413-1414.
- Langmead L, Makins RJ and Rampton DS. Anti-inflammatory effects of Aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 19;2004b: 521-527.
- Rabe T and Staden J Van. Antibacterial activity of South African plants used for medicinal purposes. Journal of Ethnopharmacology 56; 1997: 81-87.
- Davis RH, Leitner MG, Russo JM and Byrne ME. Wound healing. Oral and topical activity of Aloe vera. Journal of the American Paediatric Medical Association 79;1989: 559-562.
- Liao Z, Chen M, Tan F, Sunl X and Tang K. Microprogagation of endangered Chinese aloe Plant Cell, Tissue and Organ Culture 76;2004: 83-86.
- Zhang L and Tizard IR. Activation of mouse macrophage cell line by Acemannan; the major carbohydrate fraction of Aloe vera L. Immunopharmacology 35; 1996: 119-28.
- Nassiff HA and Fajardo F, Velez F. Effecto del aloe sobre la hiperlipidemia en pacientes refractarios a diet. Rev Cuba Med Gen Integr. 9;1993: 43-51.
- Barcroft S L and Alasdair N T. Aloe vera Healer,(www.JoJaffa.com), http://www. AloeVeraHealer.com, 1999,Accessed 11/03/09.86.
- Zhang L and Tizard IR. Activation of mouse macrophage cell line by Acemannan; the major carbohydrate fraction of Aloe vera L. Immunopharmacology 35; 1996: 119-28.
- Rolf C and Zimmerli T. Experience Aloe vera is miraculous health supporting benefits. http://wholeleaf.com 2000, Accessed 2011/08/17.
- Newall CA, Anderson LA and Phillipson JD. Herbal medicines. The pharmaceutical Press wilkensiana. Journal of Ethnopharmacology 25; 1996a: 215-220.
- Tyler VE, Brady LR and Robbers JE. Pharmacognosy. Philadelphia: Lea and Febiger 2; 1976: 81-83.]
- Anonymous. Taxon: Aloe vera (L) Burm. Germplasm Resources Information Network, United States Department of Agriculture 2008b, http://www.ars-grin.gov/cgibin/npgs/html/tax_search.pl?Aloe%20vera, Accessed 2011/08/27.
- Tyler V. Herbs of Choice: The Therapeutic Use of Phytomedicinals. Binghamton, NY: Pharmaceutical Products Press; 1994. , Brusick D, Mengs U. Assessment of the genotoxic risk from laxative senna products. Environmental and Molecular Mutagenesis 29; 1997:1-9.
- Foster S, et al. Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. New York: Haworth Herbal Press; 1999.
- Borrelli F, Izzo AA. The plant kingdom as a source of anti-ulcer remedies. Phytother Res. 14(8); 2000:581-91.
- Langmead L, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 19(7); 2004:739-47.
- Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract. 49(447); 1999:823-8.
- Himalayan Cryosphere
Authors
1 Divecha Centre for Climate Change, Indian Institute of Science, Bengaluru 560 012, IN
2 Climate Change Programme, Department of Science and Technology, New Delhi 110 016, IN
Source
Current Science, Vol 115, No 1 (2018), Pagination: 17-17Abstract
The glaciers and seasonal snow melt feed numerous Indian rivers originating from the Himalaya and support millions of people. However, snow and glaciers are sensitive to climate change and the ongoing climate change will potentially affect water availability for millions of people living in North India. Therefore, comprehensive understanding of factors and processes affecting the Himalayan cryosphere is necessary.- Plazomicin:A Step Toward Next Generation Aminoglycosides. Review
Authors
1 Surgycare Lifescience, Sendhwa (MP), IN
Source
Asian Journal of Research in Pharmaceutical Sciences, Vol 7, No 3 (2017), Pagination: 173-180Abstract
Aminoglycosides are selectively active against gram negative bacteria through inhibition of protein synthesis; moreover, those are given parenterally or topically because they are poorly absorbed from the gastrointestinal tract, therefore are given parenterally or topically. Nephrotoxicity and ototoxicity are the most common side effects associated with aminoglycosides therapy. As the resistance developed in most of the bacteria that open the door to use either most toxic combination therapy of present aminoglycosides with other antibiotics such as beta lactams or vancomycin with which they exert a synergistic effect or to discover next generation aminoglycosides, without toxicities. For the discovery of next generation aminoglycosides, a successful step passes through identification of one structure with molecular formula C25H48N6O10 and 592.68 molecular wight from 490 analogous of sisomicin with absence of 3’-OH and 4’-OH groups and named as “ACHN-490” or “Plazomicin” by Achaogen. Plazomicin showed activity against Enterobacteriaceae (EC), Multi drug resistant Enterobacteriaceae (MDR-EC), Aminoglycoside resistant Enterobacteriaceae (AR-EC), Carbapenem resistant Enterobacteriaceae (CR-EC), Colistin resistant (CR-CRE), Tigecycline resistant (TR-EC). Lack of nephrotoxicity or ototoxicity associated with plazomicin; make it drug of future in next generation aminoglycosides. In this review, I am trying to underlying discovery and development of plazomicin as newer antibiotic.Keywords
Next Generation Aminoglycoside, Plazomicin, ACGN-490, Multi-Drug Resistant Enterobacteriaceae, Aminoglycoside Resistance, Aminoglycoside Combination Therapy.References
- Baylis, C.L., Penn, C.W., Thielman, N. M. et al. (2006). Escherichia coli and Shigella spp. In Principles and Practice of Clinical Bacteriology. In P. M. Gillespie, S.H. and Hawkey (Ed.) (2nd ed., pp. 347–365). John Wiley and Sons Ltd., London.
- Cowan, S. T. (1956). Taxonomic rank of Enterobacteriaceae groups. Journal of General Microbiology, 15(2): 345–58. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/13376877.
- Pitout, J. D., and Laupland, K. B. (2008). Extended-spectrum ??-lactamase-producing enterobacteriaceae: an emerging publichealth concern. The Lancet Infectious Diseases, 8(3): 159–166. https://doi.org/10.1016/S1473-099(08)70041-0.
- Aminov, R. I. (2010). A brief history of the antibiotic era: Lessons learned and challenges for the future. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2010.00134.
- Katzung, B. G., Trevor, A. J., and Masters, S. B. (2009). Basic and Clinical Pharmacology. (C. Katzung, Bertram G.Stamford, Ed.) (7th ed.). McGraw-Hill. https://doi.org/10.1017/CBO9781107415324.004.
- Siegenthaler, W., Bonetti, A., and Luthy, R. (1986). Aminoglycoside Antibiotics in Infectious Diseases. The American Journal of Medicine, 80(6): 2-14.
- Lewis K.(2013). Platforms for antibiotic discovery. Nat Rev Drug Discov. 12(5):371-387. doi:10.1038/nrd3975.
- Devasahayam, G., Scheld, W. M., and Hoffman, P. S. (2011). Newer Antibacterial Drugs for a New Century. Expert Opinion of Investigative Drugs, 19(2): 215–234. https://doi.org/10.1517/13543780903505092.
- Shi, K., Caldwell, S. J., Fong, D. H., and Berghuis, A. M. (2013). Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance. Frontiers in Cellular and Infection Microbiology, 3(June): 1-17. https://doi.org/10.3389/fcimb.2013.00022.
- Cunha, B. a. (1988). Aminoglycosides: current role in antimicrobial therapy. Pharmacotherapy, 8(6): 334–50. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/3146747.
- Molina, J., Cordero, E., Palomino, J., and Pachón, J. (2009). [Aminoglycosides and polymyxins]. Enfermedades Infecciosas Y Microbiología Clinica, 27(3): 178–88. https://doi.org/10.1016/j.eimc.2009.02.001.
- Hira SK, Attili VR, Kamanga J, Mkandawire O, Patel JS, P. M. (1985). Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcl urethritis in Zambia. Sex Transm Dis, 1(12): 52–54.
- Yoon JY, Kim YT, K. J. (1988). Treatment of uncomplicated male gonococcal urethritis: kanamycin versus. gentamicin. Korean J Dermatol, 26(2): 184–188.
- Pareek SS, C. M. (1981). Comparative study between gentamicin and spectinomycin in the treatment of infections to penicillin-resistant gonococci. Curr Ther Res, 30(2):177–180.
- Iskandar IO, Nahuib F, G. L. EL. (1978). A comparative study of gentamicin, co-trimoxazole and trimethoprim-sulphametrol in acute gonococcal urethritis. J Egypt Med Assoc, 10(61): 489– 495.
- Lule G, Behets FM, Hoffman IF, Dallabetta G, Hamilton HA, Moeng S, Liomba G, C. M. (1994). STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med, 70(6): 384–388.
- Abbruzzese, J. L., Rocco, L. E., Laskin, O. L., Skubitz, K. M., McGaughey, M. D., and Lipsky, J. J. (1983). Prospective randomized double-blind comparison of moxalactam and tobramycin in treatment of urinary tract infections. The American Journal of Medicine, 74(4): 694–699.
- Barza M, Ioannidis JP, Cappelleri JC, Lau J. (1996). Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ (Clinical research ed.).312(7027):338-345. doi:10.1136/bmj.313.7055.490.
- Farzal, Z., Kou, Y.-F., St. John, R., Shah, G. B., and Mitchell, R. B. (2015). The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review. The Laryngoscope, 126(January): 228–235. https://doi.org/10.1002/lary.25409.
- Magiorakos, A., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2011). Bacteria : an International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Microbiology, 18(3): 268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x.
- Tolmasky, M. S. R. and M. E. (2010). Aminoglycoside Modifying Enzymes. Drug Resist Updat. 13(6): 151-171.
- Shaw, K. J., Rather, P. N., Hare, R. S., and Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiological Reviews, 57(1): 138–163.ttps://doi.org/10.1016/j.abb.2004.09.003
- Gerber AU, Vastola AP, Brandel J, C. W. (1982). Selection of aminoglycoside- resistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis, 146(5): 691–697. https://doi.org/https://doi.org/10.1093/infdis/146.5.691
- Michea-Hamzehpour M, Pechere JC, Marchou B, A. R. (1986). Combination therapy: a way to limit emergence of resistance? Am J Med, 80(6B): 138–142.
- Bliziotis, I. a, Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S., and Falagas, M. E. (2005). Effect of aminoglycoside and betalactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 41(2): 149–158. https://doi.org/10.1086/430912.
- Kahlmeter G, D. J. (1984). Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. The Journal of Antimicrobial Chemotherapy, 13 (Suppl A): 9–22.
- Kim Ming Wong, Chan YH, C. C. (2001). Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis associated peritonitis. Am J Kidney Dis, 38(1): 127–131.
- Vidal, L., Gafter-Gvili, A., Borok, S., Fraser, A., Leibovici, L., and Paul, M. (2007). Efficacy and safety of aminoglycoside monotherapy: Systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, 60(2): 247–257. https://doi.org/10.1093/jac/dkm193.
- Abrams B, Sklaver A, Hoffman T, G. R. (1979). Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med, 5(90): 789-91.
- Noone, P. (1984). Sisomicin, Netilmicin and Dibekacin: A Review of their Antibacterial Activity and Therapeutic Use. Drugs, 27(6): 548–578. https://doi.org/10.2165/00003495-198427060-00003.
- Scheetz, M. H., Hurt, K. M., Noskin, G. A., and Oliphant, C. M. (2006). Applying antimicrobial pharmacodynamics to resistant gram-negative pathogens. American Journal of Health-System Pharmacy, 63(14): 1346–1360. https://doi.org/10.2146/ajhp050403.
- S, A. E., and Miller, G. H. (2010). Combating evolution with intelligent design: the neoglycoside ACHN-490. Current Opinion in Microbiology, 13(5): 565–573. https://doi.org/10.1016/j.mib.2010.09.004.
- Galani, I. (2016). Plazomicin. Drugs of the Future, 39(1): 25–35. https://doi.org/10.1358/dof.2014.39.1.2095267
- Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., et al. (2009). ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrobial Agents and Chemotherapy, 53(10): 4504–4507. https://doi.org/10.1128/AAC.00556-09.
- Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., et al. (2010). Synthesis and spectrum of the neoglycoside ACHN-490.Antimicrobial Agents and Chemotherapy, 54(11): 4636–4642. https://doi.org/10.1128/AAC.00572-10.
- Bushb MJP and K. Investigational Antimicrobial Agents of 2013. Clin Microbiol Rev. 2013;26(4):792-821.
- James B. Aggen, Eliana S. Armstrong, Adam A. Goldblum, Paola Dozzo, Martin S. Linsell, Micah J. Gliedt, Darin J. Hildebrandt, Lee Ann Feeney, Aya Kubo, Rowena D. Matias, Sara Lopez, Marcela Gomez, Kenneth B. Wlasichuk, Raymond Diokno GHM and HEM. Synthesis and Spectrum of the Neoglycoside ACHN-490. Antimicrob Agents Chemother. 2010;54(11):4636-4642. doi:10.1128/AAC.00572-10.
- Galani I, Souli M, Daikos GL, et al. Activity of plazomicin (ACHN-490) against MDR clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Enterobacter spp. from Athens, Greece. J Chemother. 2012;24(4):191-194. doi:10.1179/1973947812Y.0000000015.
- D. M. Livermore, S. Mushtaq, M. Warner, J.-C. Zhang, S. Maharjan, M. Doumith NW. Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother. 2011;66(1):48-53. doi:10.1093/jac/dkq408.
- Landman, D. Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother. 2011;66(2):332-334. doi:https://doi.org/10.1093/jac/dkq459.
- Garcia-Salguero C, Rodriguez-Avial I, Picazo JJ, Culebras E. Can plazomicin alone or in combination be a therapeutic option against carbapenem-resistant Acinetobacter baumannii? Antimicrob Agents Chemother. 2015;59(10):5959-5966. doi:10.1128/AAC.00873-15.
- Tenover FC, Tickler I, Armstrong ES, et al. Activity of ACHN490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals. Int J Antimicrob Agents. 2011;38(4):352-354. doi:10.1016/j.ijantimicag.2011.05.016.
- Karaiskos I, Souli M, Giamarellou H. Plazomicin: an investigational therapy for the treatment of urinary tract infections. Expert Opin Investig Drugs. 2015;24(11):1501-1511. doi:10.1517/13543784.2015.1095180.
- Noe Reyes JBA and CFK. In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models. Antimicrob Agents Chemother. 2011;55(4):1728-1733.
- Lin G1, Ednie LM AP. Antistaphylococcal activity of ACHN490 tested alone and in combination with other agents by time-kill assay. Antimicrob Agents Chemother. 2010;54(5):2258-2261.
- Cass RT1, Brooks CD, Havrilla NA, Tack KJ, Borin MT, Young D BJ. Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects. Antimicrob Agents Chemother. 2011;55(12):5874-5880.
- Indian Science and Conflict of Interest
Authors
1 Department of Science and Technology, New Delhi 110 016, IN
Source
Current Science, Vol 115, No 6 (2018), Pagination: 1020-1020Abstract
This is in response to the editorial titled ‘Is Indian science ready to tackle conflict of interest in a rational way?’ by E. Arunan.References
- Arunan, E., Curr. Sci., 2018, 114, 1385– 1386.
- Subrahmanyan, R., Curr. Sci., 2018, 115(2), 193.
- Swarup, G., Curr. Sci., 2018, 115(3), 369.
- Mohan, P. and Brakaspathy, R., Curr. Sci., 2018, 114(9), 1835–1839.
- Pharmacoepidemiology of Severe Systemic Infection and Need of Netilmicin Monotherapy or Combination Therapy:Systemic Review and Meta- Analysis
Authors
1 Surgycare Lifescience, Sendhwa (MP), IN
2 SND College of Pharmacy, Yeola (MS), IN
3 RD Memorial Ayurvedic College, Bhopal (MP), IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 9, No 3 (2017), Pagination: 101-108Abstract
In this systematic review and meta-analysis we compared the efficacy and safety in patient with severe systemic infection (SSF) who has been either on netilmicin (NL) monotherapy or combination of netilmicin with other antibiotics (NLC). A systematic review of the literature was performed in accordance with PRISMA guidelines in Medline and Embase. A comprehensive search was performed from 1978 to 2017. Total 17 studies were identified that include 976 randomized patients with SSF. 489 patients enrolled in 11 studies for NL while 487 in NLC group. The meta-analysis showed that there was a statistically significant difference in rate of clinical efficacy (rate of failure) between NL (13.09%) and comparator NLC (20.91%). Nephrotoxicity associated with the therapy showed minor difference between both group, NL (13.80%) and NLC (10.09%). The study was further compare on the basis of dose regimen viz once a day (OD) and three times a day (TID). 184 patients of 4 studies received once in a day netilmicin monotherapy (OD-NL) while 259 patients of 7 studies received three times a day netilmicin monotherapy (TID-NL).Result of dose regimen group showed 11.04% rate of failure and 11.78% incidence of nephrotoxicity in (OD-NL) and 12.5% and 13.84% respectively in (TID-NL).The paucity of data from this evidence based systematic review and meta-analysis, favors NL monotherapy, if the slightly more chances of nephrotoxicity than comparator NLC neglected.Keywords
Netilmicin, Sever Infection, Netilmicin Combination Therapy, Nephrotoxicity, Meta Analysis.References
- Matthieu L, Adeline M, Benoit S et al. The strategy of antibiotic use in critically ill neutropenic patients. Ann Intensive Care. 2012; 2:1-9.
- Kibe S, Adams K, Barlow G et al. Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother. 2011; 66:33-40.
- Chesney RW, McCarren DM, Haddad JG, et al. Pathogenic mechanisms of the hypocalcaemia of the staphylococcal toxic shock syndrome. J Lab Clin Med. 1983; 101:576-85.
- Charles VP. Current status of combined antibiotic therapy. J Pediatrics. 1958; 21:1000-09
- Tamma PD, Cosgrove SE, Maragakis LL. Combination therapy for treatment of infections with gram-negative bacteria. Clin Microbiol Rev. 2012; 25:450–70.
- Lubos D, Giampaolo B, Thierry C et al. The need for aminoglycosides in combination with β-lactams for high-risk, febrile neutropaenic patients with leukaemia. Eu J Canc Supp. 2007; 5:13-22
- Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin N Am. 2003; 17:503-28.
- Dana Maglio, Extended interval aminoglycoside dosing: from concept to clinic. Int J Antimicrob Agents. 2002; 19:341-8.
- Kim Ming Wong, Chan YH, Cheung CY et al. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis associated peritonitis. Am J Kidney Dis. 2001;38: 127-31
- Endre L et al. Efficacy and safety of ceftriaxone plus netilmicin once daily versus ceftazidime plus netilmicin twice daily in severe nosocomial infections. Cur Therap Research. 1993; 53:687-92.
- Perazella MA. Toxic Nephropathies: Core Curriculum 2010. Am J Kidney Dis. 2010; 55:399-09.
- Broe ME, Giuliano RA, Verpooten GA. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity. Am J Med. 1986; 80:115-8.
- Gonzalez US, Spencer JP. Aminoglycosides: a practical review. Am Fam Physician. 1998; 58:1811-20.
- Richard A, Krieger JN. Gentamicin for the practicing urologist: review of efficacy, single daily dosing and "switch" therapy. J Urology. 2000; 163: 1076-84
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6:1000-10.
- DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.1986; 7: 177–88.
- Alessandra V Nicolia P, Luca B et al. Comparison of 5 Milligrams of netilmicin per kilogram of body weight once daily versus 2 milligrams per kilogram thrice daily for treatment of gramnegative pyelonephritis in children, J Antimicrob agents and chemother. 1992; 36: 1499-03
- Auwera P, Meunier F, Ibrahim S et al. Pharmacodynamic parameters and toxicity of netilmicin (6Milligrams/Kilogram/Day) given once daily or in three divided doses to cancer patients with urinary tract infection. J Antimicrob agents and chemother. 1991; 35: 640-7.
- Prat V, Horcicková M, Hatala M et al. Long-term effect of the administration of repeated single doses of netilmicin in urinary tract infections, Cas Lek Cesk. 1990;129:306-8.
- Donald K, Irwin T, James P et al. Pharmacology and efficacy of netilmicin. J Antimicrob agents and chemother. 1978; 13: 832-6.
- Richard DM, Bonnie VB, Paul HE et al. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin. J Antimicrob agents and chemother. 1980; 17:217-25.
- Michael B, Michael WL, Francis PT et al. Prospective randomized trial of netilmicin and amikacin, with emphasis on eighth nerve toxicity. J Antimicrob agents and chemother. 1980; 17:707-14.
- Tange RA, Dreschler WA, Prins JM et al. Ototoxicity and nephrotoxicity of gentamicin vs netilmicin in patients with serious infections. A randomized clinical trial. Clin Otolaryngol Allied Sci. 1995; 20:118-23.
- Hellum KB, Madsen ST, Digranes A et al. High dose netilmicin therapy of severe or chronic infections. Scand J Infect Dis Suppl. 1980; 23:189-94.
- Perera MR, Amirak ID, Noone P. Netilmicin 200 mg twice a day for adult patients with life-threatening infections. A preliminary report. Scand J Infect Dis Suppl. 1980; 23:186-8.
- Jahre JA, Fu KP , Neu HC. Clinical evaluation of netilmicin therapy in serious infections. AM J Med 1979; 66:67-73.
- Zhao CA, Li J, Hou J, Guo M et al. Randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections. J Chin Med. 2000; 113:1026-30.
- Cometta A, Baumgartner JD, Lew D et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patientst. J Antimicrob agents and chemother. 1994; 38: 1309-13.
- CHEK CC, Beryl AP, Heather A et al. Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. J Antimicrob agents and chemother. 1989; 33: 87-91.
- Nasu M, Goto Y, Yamasaki T et al. Clinical studies on the time-difference combination therapy with netilmicin and minocycline in methicillin resistant staphylococcus aureus infections Jpn J Antibiot. 1994; 47:1305-17.
- Hoffken G, Pasold R, Pfluger KH et al. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients J Antimicr Chemo. 1999; 44: 367–76.
- Bubrick MP, Howard RJ , Pancorbo S et al. A comparative study of netilmicin-cefoxitin and gentamicin-cefoxitin in surgical patients with serious systemic infection. Clin Therapeutics. 1983; 5:515-24.
- Kahalley S, Chandler J , Hawkins J et al. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections. Clin Therapeutics. 1985; 7:497-06.
- Formulation and Evaluation of Floating Matrix Tablets of Acyclovir using 32 Factorial Design
Authors
1 SND College of Pharmacy, Babhulgaon, Yeola, Nashik, IN
2 Surgycare Lifescience, Sendhwa, M. P., IN
Source
Research Journal of Pharmaceutical Dosage Form and Technology, Vol 10, No 1 (2018), Pagination: 1-9Abstract
Floating Drug Delivery Systems (FDDS) have a bulk density lower than gastric fluids and thus remain buoyant in the stomach for a prolonged period of time, without affecting the gastric emptying rate. While the system is floating on the gastric contents, the drug is released slowly at a desired rate from the system. These floating tablets mainly prepared for reduction of lag time and release the drug up to 12 hours and may also increase the bioavailability of the drugs by utilizing the drug to full extent avoiding unnecessary frequency of dosing. The study included formulation of floating tablets using polymers like Hydroxy propyl methyl cellulose K15M, PVP K30, Sodium bicarbonate, Xanthan-Gum, Guar-gum and microcrystalline cellulose as matrix forming agents. The tablets were directly compressed using Lab Press multi station rotary punching machine. FTIR and DSC-TGA studies conformed that there was no incompatibility between the polymers and the drug. Tablet preformulation parameters were within the Pharmacopoeias limit. Tablet showed zero lag time, continuance of buoyancy for >12 h. In vivo X-ray studies depicted that tablets continued to float in the GIT for 12 h. The in-vitro drug release pattern of Acyclovir floating tablets was fitted to different kinetic models which showed highest regression for zero order kinetics with Koresmeyer-peppasand most of the formulations followed Nonfickian diffusion.Keywords
Acyclovi, Floating Drug Delivery System, HPMC, PVP K30, Xanthan-Gum, Guar-Gum, Matrix Devices, Gastroretentive Dosage Forms.References
- Moffat, A. C, Osselton, M. D, Widdop, B. Clarke’s Analysis of Drugs and Poisons. Pharma ceutical Press, London, 2004 2(3), 582.
- Sweetman, S. C. Martindale. Pharmaceutical Press, London, 2005, (34), 626.
- Gisbold‟ s Willson. Text Book of Organic Medicinal and Pharmaceutical Chemistry, Lippincott Williams and Wilkins, New York. London. 2004, (11) 372.
- Tripathi KD, Essential of Medical Pharmacology, Jaypee Brothers, Medical, Publisher, (P) LTD, New Delhi. 2008, (6) 767.
- Mridanga R.R, Bose S.K. and Sengupta K. Design, Development and in vitro evolution of directly compressed sustained release matrix tablet of famotidine. Research J. Pharm and Tech., 2008, 1(3): 175-178.
- Ajay B, Dinesh KP, Pradeep S. Studies on formulation and evaluation of floating tablets ofciprofloxacin. Int J Compren Pharma. 2010; 5(2): 1-3.
- Rocca JG, Omidian H, Shah K. Progress in Gastro retentive drug delivery system, Drug Delivery Oral. Pharm.Tech. 2003; 152–156.
- M, Zia H, Rhodes T. Design and testing in vitro of a bioadhesive and floatingdrugdelivery system for oral application. Int J Pharm. 1994; 105(1): 65-70.
- Sheth PR, Tossounian J. The hydrodynamically balanced system (HBS): a novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 1994; 20: 313–339.
- Krunal PM, Biswajit B, Nabin K, Janki P. Preparation and evaluation of gastro retentivefloating tablets of mebendazole. Int J Curr Pharma Res. 2011; 3(1): 63-65.
- Sheth PR, Tossounian J. The hydrodynamically balanced system (HBS): a novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 1994; 20: 313–339.
- Jadhav MN, Shanmugam S, Sundaramoorthy K, Ayyappan T, Vetrichelvan T.Formulation and in-vitro evaluation of gastro retentive floating matrix tablets of famotidine. Int J Pharma and Bio Sci, 2010; 4(1): 548-58.
- Friend DR. Oral delivery: A new approach to dosage forms. Pharmaceutical News 2002; 9: 375-80.
- Chein YW. Oral Drug Delivery and Delivery systems. In, Novel drug delivery Systems, Marcel Dekker, Inc, New York, 1992, 50(4), 139-177.
- Kavitha K, Puneeth KP, Tamizh MT. Development and evaluation of rosiglitazone maleatefloating tablets using natural gums. IJPT Res. 2010; 2(3): 1662-66.
- Orazio Luca Strusi, Gaia Colombo, Pedro Barata, Paolo Colombo. Module assemblage technology for floating systems: In vitro flotation and in vivo gastro-retention. J Control release; 2008, 129(3), 188-192.
- Gambhire MN, Ambade KW, Kurmi SD, Kadam VJ, Jadhav KR., Development and invitro evaluation of an oral floating matrix tablet formulation of Diltiazem hydrochloride, AAPS Pharm Sci Tech, 2007; 8(3): E 73.
- Patel SS, Ray S, Thakur RS., Formulation and evaluation of floating drug delivery system containing Clarithromycin for Helicobacter pylori, Acta Pol Pharm, 2006; 63(1): 53-61.
- Jaimini M, Rana AC, Tanwar YS., Formulation and evaluation of Famotidine floating tablets, Curr Drug Deliv. 2007; 4(1): 51-5.
- Thahera PD, Ashok, Latha K, Shailaja T, Nyamathulla S, UhumwanghoMU,Formulation and evaluation of Norfloxacin gastroretentive drug delivery systems using natural polymers, International current pharmaceutical journal, 2012; 1(7): 155-164.
- Patel Ishvar C, Hariprasnna RC, Mohan V Kodli, Patel vishal A, Pentewar Ram P,Formulation and evaluation of floating matrix tablets of Ketorolac tromethamine, IJPI’S Journal of pharmaceutics and Cosmetology, 2011; 2: 7.
- Gohel MC, Mehta PR, Dave PK, Bariya NH. More relevant dissolution method for evaluation of PDDS. Dissolution technol, 2005; 11: 22‐5.
- Swarna Kamala Chinthala CH, Srinivas Reddy Kota K, Hadassah M, HepsibhaMetilda E,Sridevi S, Fomulation and evaluation of gastroretentive floating tablets of Gabapentin using Effervescent technology, Int J Pharm Biomed Res 2012; 3(4): 202-208.
- Patel Sanjay S, Ray S. and Thakur R. S. Formualtion and evaluation of floating drug delivery system containing clarithromycin for Helicobacter Pylori. Acta Pol Pharma Dr Res, 2006, 63(1) 53-61.
- B, Dinesh KP, Pradeep S. Studies on formulation and evaluation of floating tablets ofciprofloxacin. Int J Compren Pharma. 2010; 5(2): 1-3.
- SERB-SURE Scheme in India: Early Indicators and Recommendations
Authors
1 Department of Science and Technology, Centre for Policy Research, Indian Institute of Science, Bengaluru, IN
2 Science and Engineering Research Board, New Delhi 110 016, IN
3 Department of Science and Technology, and Science and Engineering Research Board, New Delhi 110 016, IN
Source
Current Science, Vol 125, No 9 (2023), Pagination: 934-938Abstract
State-level institutes have an important role in strengthening the national STI ecosystem. SERB-SURE scheme was launched in 2022 to support research at state-level institutes to strengthen the national STI ecosystem. The scheme also promotes researchers with no ongoing/completed project proposals under SERB and thus is a platform to appraise the upcoming talent pool of the country. The details of proposals submitted and recommended have been gathered from the PRISM website and SERB online portal. The present article quantitatively analyses the trend of project proposal submission and approval based on parameters such as gender, state, institute type and subject area between the financial year 2022–23. Based on these early indicators, some recommendations for promoting research at state-level institutes are provided here.Keywords
Government Programme, Research in India, Schemes, Science, SERB, SURE, Technology.References
- AISHE 2021; https://aishe.gov.in/aishe/home
- Research and Development Statistics, 2022–23; www.nstmis-dst.org
- DST India 2023; www.dst.gov.in
- Agarwal, M., Role of J.C. Bose Fellowship in empowering women scientists in India. Curr. Sci., 2022, 123(11), 1305–1308.
- Kanaujia, A., Singh, P., Nandy, A. and Singh, V. K., Research contribution of major centrally funded institution systems of India. Curr. Sci., 2022, 123(9), 1082–1088.
- Chakraborty, K., Upadhyaya, N. and Upadhyay, R. S., Explored publication pattern of the top twenty NIRF-2020 ranked Indian institutions: an evaluative study. Libr. Philos. Pract., 2021, 5385, 1–18; https://digitalcommons.unl.edu/libphilprac
- Banshal, S. K., Singh, V. K., Base, A. and Muhuri, P. K., Comparing research performance of Indian Institutes of Technology. Curr. Sci., 2019, 116(8), 1304–1313.
- ARWS Ranking 2022; https://www.shanghairanking.com/rankings/arwu/2022
- QS Global Ranking 2023; https://www.topuniversities.com/university-rankings/world-university-rankings/2023
- PRISM-SERB 2023; https://prism.serbonline.in (accessed on 20 March 2023).
- https://www.serbonline.in/SERB/Sure (accessed on 12 March 2023).
- Agarwal, M. and Kaur, P., Impact of selected schemes of SERB: empowering Indian women in R&D spectrum. ACS Omega, 2023; https://doi.org/10.1021/acsomega.3c03826.
- Kanaujia, A., Nandy, A., Singh, P. and Singh, V. K., Mapping the research output from Indian states, Curr. Sci., 2023, 124(11), 1245–1255.